Ablation with Low-Dose Radioiodine and Thyrotropin Alfa in Thyroid Cancer

Ujjal K. Mallick, Clive Harmer, B. Yap, +25

New England Journal of Medicine

Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial

Beatrice Seddon, Sandra J. Strauss, Jeremy Whelan, +16

The Lancet Oncology

Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial

Juan W. Valle, Harpreet Wasan, Andre Lopes, +16

The Lancet Oncology

Surgical OncologyGastrointestinal OncologyMedicineBiliary CancerRandomised Phase 2 +6

Best time to assess complete clinical response after chemoradiotherapy in squamous cell carcinoma of the anus (ACT II): a post-hoc analysis of randomised controlled phase 3 trial

Rob Glynne‐Jones, David Sebag‐Montefiore, Helen Meadows, +9

The Lancet Oncology

A randomised phase II/III trial of 3-weekly cisplatin-based sequential transarterial chemoembolisation vs embolisation alone for hepatocellular carcinoma

Tim Meyer, Amy A. Kirkwood, Sandy Beare, +11

British Journal of Cancer

Effect of Single-Fraction vs Multifraction Radiotherapy on Ambulatory Status Among Patients With Spinal Canal Compression From Metastatic Cancer

Peter Hoskin, Kirsten Hopkins, Vivek Misra, +21

JAMA

A phase I dose-escalating study of DaunoXome, liposomal daunorubicin, in metastatic breast cancer

Kenneth J. O’Byrne, Anne Thomas, Ricky A. Sharma, +4

British Journal of Cancer

Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed colorectal cancer: the prospective Streamline C trial

Stuart A. Taylor, Sandy Beare, Gauraang Bhatnagar, +198

˜The œLancet. Gastroenterology & hepatology

Whole-body MRI compared with standard pathways for staging metastatic disease in lung and colorectal cancer: the Streamline diagnostic accuracy studies

Stuart A. Taylor, Susan Mallett, Anne Miles, +15

Health Technology Assessment

Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed non-small-cell lung cancer: the prospective Streamline L trial

Stuart A. Taylor, Simon Ball, Sandy Beare, +199

The Lancet Respiratory Medicine